Umbilical vein injection for retained placenta: clinical feasibility study of a new technique

East Afr Med J. 1994 Jun;71(6):396-7.

Abstract

Intraumbilical oxytocin infusion for retained placenta is a relatively new and promising technique. We have tested the clinical feasibility of different infusion techniques in this study. Nine patients had intraumbilical infusions through a mucus aspiration catheter and 12 by an 18 gauge needle. Infusion was successful in 7(77.7%) of 9 cases following catheterisation and in 7(58.3%) of 12 cases following direct injection. Both techniques were clinically feasible, but direct injection was somewhat easier than catheterisation. The importance of non-operative management of retained placenta, particularly in areas with limited medical facilities, is discussed and an approach to the management of retained placenta proposed.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Catheters, Indwelling
  • Clinical Protocols
  • Feasibility Studies
  • Female
  • Humans
  • Infusions, Parenteral / instrumentation
  • Infusions, Parenteral / methods*
  • Needles
  • Oxytocin / therapeutic use*
  • Placenta, Retained / drug therapy*
  • Pregnancy
  • Time Factors
  • Traction
  • Treatment Outcome
  • Umbilical Veins*

Substances

  • Oxytocin